|
Name |
2-Hydroxypurine
|
Molecular Formula | C5H4N4O | |
IUPAC Name* |
3,7-dihydropurin-2-one
|
|
SMILES |
C1=NC(=O)NC2=C1NC=N2
|
|
InChI |
InChI=1S/C5H4N4O/c10-5-6-1-3-4(9-5)8-2-7-3/h1-2H,(H2,6,7,8,9,10)
|
|
InChIKey |
CRIZPXKICGBNKG-UHFFFAOYSA-N
|
|
Synonyms |
2-Hydroxypurine; 2308-57-8; 2-Oxopurine; 1h-purin-2-ol; 3,7-dihydropurin-2-one; 2H-Purin-2-one, 1,3-dihydro-; 2-Purinol; 51953-15-2; 7H-Purin-2-ol; 95121-01-0; Purin-2-ol; Purin-2(1H)-one; 1,3-Dihydro-2H-purin-2-one; oxypurine; oxodihydropurine; 2OH-Purine; 9H-Purin-2-ol #; 3,9-dihydropurin-2-one; 9H-Purin-2-ol(9ci); SCHEMBL276945; 2,9-dihydro-1H-purin-2-one; DTXSID70177652; 2H-Purin-2-one, 1,3-dihydro; ZINC18042886; AKOS006343507
|
|
CAS | 2308-57-8 | |
PubChem CID | 75323 | |
ChEMBL ID | CHEMBL434384 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 136.11 | ALogp: | -0.5 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 70.1 | Aromatic Rings: | 2 |
Heavy Atoms: | 10 | QED Weighted: | 0.538 |
Caco-2 Permeability: | -4.709 | MDCK Permeability: | 0.00000656 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.807 |
Human Intestinal Absorption (HIA): | 0.015 | 20% Bioavailability (F20%): | 0.575 |
30% Bioavailability (F30%): | 0.045 |
Blood-Brain-Barrier Penetration (BBB): | 0.128 | Plasma Protein Binding (PPB): | 22.47% |
Volume Distribution (VD): | 0.914 | Fu: | 71.68% |
CYP1A2-inhibitor: | 0.043 | CYP1A2-substrate: | 0.922 |
CYP2C19-inhibitor: | 0.043 | CYP2C19-substrate: | 0.055 |
CYP2C9-inhibitor: | 0.009 | CYP2C9-substrate: | 0.292 |
CYP2D6-inhibitor: | 0.01 | CYP2D6-substrate: | 0.063 |
CYP3A4-inhibitor: | 0.018 | CYP3A4-substrate: | 0.17 |
Clearance (CL): | 10.086 | Half-life (T1/2): | 0.927 |
hERG Blockers: | 0.029 | Human Hepatotoxicity (H-HT): | 0.541 |
Drug-inuced Liver Injury (DILI): | 0.976 | AMES Toxicity: | 0.025 |
Rat Oral Acute Toxicity: | 0.413 | Maximum Recommended Daily Dose: | 0.215 |
Skin Sensitization: | 0.676 | Carcinogencity: | 0.046 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.471 |
Respiratory Toxicity: | 0.272 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001061 | 0.308 | D04KYY | 0.450 | ||||
ENC000011 | 0.289 | D09UZO | 0.381 | ||||
ENC000065 | 0.244 | D0S5WG | 0.359 | ||||
ENC000063 | 0.233 | D02ZXM | 0.333 | ||||
ENC000599 | 0.214 | D08IBS | 0.289 | ||||
ENC001997 | 0.200 | D09AMZ | 0.259 | ||||
ENC001638 | 0.197 | D06FDR | 0.238 | ||||
ENC003988 | 0.191 | D05LEO | 0.233 | ||||
ENC002926 | 0.188 | D0F8RA | 0.231 | ||||
ENC002473 | 0.180 | D03OIW | 0.203 |